<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0001336"><a href="http://purl.obolibrary.org/obo/MONDO_0001336">MONDO:0001336</a></h3>
<p><strong>Label:</strong> familial hyperlipidemia</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0018328">MONDO:0018328</a> (homozygous familial hypercholesterolemia), <a href="http://purl.obolibrary.org/obo/MONDO_0005439">MONDO:0005439</a> (familial hypercholesterolemia), <a href="http://purl.obolibrary.org/obo/MONDO_0001807">MONDO:0001807</a> (familial combined hyperlipidemia), <a href="http://purl.obolibrary.org/obo/MONDO_0007750">MONDO:0007750</a> (hypercholesterolemia, familial),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_477811">Orphanet:477811</a>, <a href="http://purl.obolibrary.org/obo/OMIM_144250">OMIM:144250</a>, <a href="http://purl.obolibrary.org/obo/OMIM_144010">OMIM:144010</a>, <a href="http://purl.obolibrary.org/obo/OMIM_143890">OMIM:143890</a>, <a href="http://www.orpha.net/ORDO/Orphanet_391665">Orphanet:391665</a>, <a href="http://purl.obolibrary.org/obo/OMIM_603776">OMIM:603776</a>, <a href="http://purl.obolibrary.org/obo/OMIM_602247">OMIM:602247</a>, <a href="http://purl.obolibrary.org/obo/OMIM_603813">OMIM:603813</a>, <a href="http://www.orpha.net/ORDO/Orphanet_406">Orphanet:406</a>, <a href="http://purl.obolibrary.org/obo/OMIM_144400">OMIM:144400</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0000991">HP:0000991</a> (Xanthomatosis) and <a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) 67.26%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) and <a href="http://purl.obolibrary.org/obo/HP_0011492">HP:0011492</a> (Abnormality of corneal stroma) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) and <a href="http://purl.obolibrary.org/obo/HP_0008011">HP:0008011</a> (Peripheral opacification of the cornea) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) and <a href="http://purl.obolibrary.org/obo/HP_0007957">HP:0007957</a> (Corneal opacity) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) and <a href="http://purl.obolibrary.org/obo/HP_0007759">HP:0007759</a> (Opacification of the corneal stroma) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001084">HP:0001084</a> (Corneal arcus) and <a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000481">HP:0000481</a> (Abnormality of the cornea) and <a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) and <a href="http://purl.obolibrary.org/obo/HP_0012374">HP:0012374</a> (Abnormality of the globe) and <a href="http://purl.obolibrary.org/obo/HP_0025015">HP:0025015</a> (Abnormal vascular morphology) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) and <a href="http://purl.obolibrary.org/obo/HP_0012372">HP:0012372</a> (Abnormal eye morphology) and <a href="http://purl.obolibrary.org/obo/HP_0025015">HP:0025015</a> (Abnormal vascular morphology) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) and <a href="http://purl.obolibrary.org/obo/HP_0011004">HP:0011004</a> (Abnormal systemic arterial morphology) and <a href="http://purl.obolibrary.org/obo/HP_0012374">HP:0012374</a> (Abnormality of the globe) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) and <a href="http://purl.obolibrary.org/obo/HP_0011004">HP:0011004</a> (Abnormal systemic arterial morphology) and <a href="http://purl.obolibrary.org/obo/HP_0012372">HP:0012372</a> (Abnormal eye morphology) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) and <a href="http://purl.obolibrary.org/obo/HP_0007957">HP:0007957</a> (Corneal opacity) and <a href="http://purl.obolibrary.org/obo/HP_0011492">HP:0011492</a> (Abnormality of corneal stroma) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002634">HP:0002634</a> (Arteriosclerosis) and <a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) and <a href="http://purl.obolibrary.org/obo/HP_0012374">HP:0012374</a> (Abnormality of the globe) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002634">HP:0002634</a> (Arteriosclerosis) and <a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) and <a href="http://purl.obolibrary.org/obo/HP_0012372">HP:0012372</a> (Abnormal eye morphology) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002621">HP:0002621</a> (Atherosclerosis) and <a href="http://purl.obolibrary.org/obo/HP_0003124">HP:0003124</a> (Hypercholesterolemia) and <a href="http://purl.obolibrary.org/obo/HP_0012374">HP:0012374</a> (Abnormality of the globe) 65.00%</li>
</ul>
</body>
</html>
